The CC genotype of rs10046, one of the most extensively studied CYP19A1 candidate SNPs, was found associated with a longer disease-free survival of premenopausal, but not postmenopausal breast cancer patients [33]. This evidence concerns the gene CYP19A1 and breast carcinoma.